Welcome to LookChem.com Sign In|Join Free

CAS

  • or

107367-98-6

Post Buying Request

107367-98-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107367-98-6 Usage

Description

2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid is a chemical compound characterized by the presence of an oxazole ring—a five-membered heterocyclic ring with one oxygen and one nitrogen atom, along with three carbon atoms. This specific compound features a 5-methyl-2-phenyl substitution on the oxazole ring, and an acetic acid ester is attached to the 2nd carbon atom. Although its physical properties and potential applications are not extensively studied, the general presence of oxazoles in various bioactive compounds suggests that this compound may hold significant therapeutic potential, warranting further research.

Uses

Given the limited information on the specific applications of 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid, the following uses are inferred based on the general utility of oxazole-containing compounds in the pharmaceutical and chemical industries:
Used in Pharmaceutical Industry:
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid is used as a building block or intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs with diverse therapeutic benefits. The presence of the oxazole ring may enhance the compound's bioactivity, making it a valuable component in medicinal chemistry.
Used in Chemical Research:
In the field of chemical research, 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid serves as a subject for investigation to explore its physical and chemical properties, as well as its reactivity with other compounds. Understanding these properties can lead to the discovery of new reactions or applications in organic synthesis.
Used in Bioactive Compounds Development:
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid is utilized as a key structural element in the design and synthesis of bioactive compounds, potentially leading to the creation of novel agents with applications in various therapeutic areas, given the known importance of oxazoles in natural and synthetic bioactive molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 107367-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,3,6 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 107367-98:
(8*1)+(7*0)+(6*7)+(5*3)+(4*6)+(3*7)+(2*9)+(1*8)=136
136 % 10 = 6
So 107367-98-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO3/c1-8-10(7-11(14)15)13-12(16-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3,(H,14,15)

107367-98-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID

1.2 Other means of identification

Product number -
Other names 2-Phenyl-5-methyloxazol-4-ylacetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107367-98-6 SDS

107367-98-6Relevant articles and documents

Design and synthesis of Oxime ethers of β-oxo-γ-phenylbutanoic acids as PPAR a and -γ dual agonists

Han, Hee Oon,Koh, Jong Sung,Kim, Seung Hae,Park, Ok Ku,Kim, Kyoung-Hee,Jeon, Sang Kweon,Hur, Gwong-Cheung,Yim, Hyeon Joo,Kim, Geun Tae

, p. 1979 - 1982 (2012/08/14)

Oxime ethers of p-oxo-y-phenylbutanoic acids were prepared to develop more effective PPAR a and y dual agonists. Among them, compound 11k exhibited potent in vitro activities with EC50 of 2.5 nM and 3.3 nM in PPAR a and y, respectively. It showed better g

Design and synthesis of oxime ethers of α-acyl-β-phenylpropanoic acids as PPAR dual agonists

Oon Han, Hee,Hae Kim, Seung,Kim, Kyoung-Hee,Hur, Gwong-Cheung,Joo Yim, Hyeon,Chung, Hee-Kyung,Ho Woo, Sung,Dong Koo, Ki,Lee, Chang-Seok,Sung Koh, Jong,Tae Kim, Geun

, p. 937 - 941 (2007/10/03)

Oxime ethers of α-acyl-β-phenylpropanoic acids were prepared to apply as PPARα and γ dual agonists. Among them, compound 11l proved to exhibit potent in vitro activities with EC50 of 19 and 13 nM in PPARα and γ, respectively. It showed better g

Antidiabetic agents

-

, (2008/06/13)

The present invention provides compounds of Formula (I): wherein A, X, Q, Y, B, D, Z, and E have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antidiabetic agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 107367-98-6